- Report
- May 2024
- 139 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 134 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 140 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 129 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 130 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 128 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 134 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2024
- 139 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2023
- 116 Pages
Global
From €4086EUR$4,500USD£3,503GBP
- Report
- July 2024
- 139 Pages
Global
From €2270EUR$2,500USD£1,946GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2270EUR$2,500USD£1,946GBP
- Report
- January 2026
- 70 Pages
Indonesia
From €4313EUR$4,750USD£3,697GBP
- Report
- May 2025
- 106 Pages
Global
From €4313EUR$4,750USD£3,697GBP
- Report
- July 2024
- 70 Pages
Global
From €4313EUR$4,750USD£3,697GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4313EUR$4,750USD£3,697GBP
- Report
- July 2024
- 70 Pages
Global
From €4313EUR$4,750USD£3,697GBP
- Report
- February 2024
- 181 Pages
Europe
From €4313EUR$4,750USD£3,697GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4313EUR$4,750USD£3,697GBP
- Report
- February 2024
- 85 Pages
North America
From €4313EUR$4,750USD£3,697GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4313EUR$4,750USD£3,697GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more